- AuthorisedTherapeutic use (Phase IV)
Impact of EXercise on quality of life of early breast cancer patients on treatment with adjuvant Aromatase Inhibitors with or without CDK4/6 inhibitors. "The EX-AI study"
This study looks at how exercise affects the quality of life for women with early breast cancer. These women are taking hormone treatments, sometimes with another medicine called a CDK4/6 inhibitor. The study wants to see if exercise helps with symptoms and overall well-being.
For: Early Breast CancerSpain - AuthorisedTherapeutic confirmatory (Phase III)
One multicenter, randomized, open, phase III clinical study on SHR3680 combined with androgen deprived therapy (ADT) versus Bicalutamide combined with ADT in treatment of metastatic hormone-sensitive prostate cancer with high tumor load.
This study is looking at a new treatment called SHR3680 for men with prostate cancer that has spread. It compares SHR3680 plus standard hormone therapy against another common treatment, Bicalutamide, plus standard hormone therapy, to see which works better and is safer.
For: Metastatic hormone-sensitive prostate cancer with high tumor loadCzechia · Bulgaria · Poland